A detailed history of Victory Capital Management Inc transactions in Insmed Inc stock. As of the latest transaction made, Victory Capital Management Inc holds 455,959 shares of INSM stock, worth $35.8 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
455,959
Previous 147,140 209.88%
Holding current value
$35.8 Million
Previous $9.86 Million 237.64%
% of portfolio
0.03%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$62.0 - $79.01 $19.1 Million - $24.4 Million
308,819 Added 209.88%
455,959 $33.3 Million
Q2 2024

Aug 05, 2024

BUY
$22.0 - $69.71 $2.82 Million - $8.93 Million
128,098 Added 672.71%
147,140 $9.86 Million
Q1 2024

May 03, 2024

BUY
$25.72 - $29.94 $6,301 - $7,335
245 Added 1.3%
19,042 $516,000
Q4 2023

Feb 05, 2024

BUY
$23.42 - $31.74 $77,543 - $105,091
3,311 Added 21.38%
18,797 $582,000
Q3 2023

Nov 06, 2023

BUY
$19.86 - $26.93 $18,827 - $25,529
948 Added 6.52%
15,486 $391,000
Q2 2023

Jul 27, 2023

SELL
$16.44 - $21.1 $5,573 - $7,152
-339 Reduced 2.28%
14,538 $306,000
Q1 2023

May 02, 2023

SELL
$16.26 - $21.73 $3,105 - $4,150
-191 Reduced 1.27%
14,877 $253,000
Q4 2022

Feb 10, 2023

BUY
$16.98 - $23.15 $2,309 - $3,148
136 Added 0.91%
15,068 $301,000
Q4 2022

Feb 09, 2023

SELL
$16.98 - $23.15 $382,202 - $521,083
-22,509 Reduced 60.12%
14,932 $298,000
Q3 2022

Nov 02, 2022

BUY
$20.88 - $28.21 $497,779 - $672,526
23,840 Added 175.28%
37,441 $807,000
Q2 2022

Aug 01, 2022

BUY
$17.07 - $25.71 $2,492 - $3,753
146 Added 1.09%
13,601 $268,000
Q1 2022

May 04, 2022

SELL
$20.42 - $28.13 $10,087 - $13,896
-494 Reduced 3.54%
13,455 $296,000
Q4 2021

Feb 07, 2022

SELL
$25.89 - $33.45 $1,398 - $1,806
-54 Reduced 0.39%
13,949 $380,000
Q3 2021

Nov 02, 2021

SELL
$22.46 - $29.47 $22,909 - $30,059
-1,020 Reduced 6.79%
14,003 $386,000
Q2 2021

Aug 03, 2021

BUY
$24.17 - $36.01 $71,833 - $107,021
2,972 Added 24.66%
15,023 $428,000
Q1 2021

May 04, 2021

BUY
$32.28 - $44.3 $8,909 - $12,226
276 Added 2.34%
12,051 $410,000
Q4 2020

Feb 01, 2021

BUY
$31.45 - $40.54 $20,253 - $26,107
644 Added 5.79%
11,775 $392,000
Q3 2020

Nov 09, 2020

SELL
$26.0 - $34.5 $37,440 - $49,680
-1,440 Reduced 11.45%
11,131 $358,000
Q2 2020

Aug 07, 2020

BUY
$14.11 - $29.42 $21,588 - $45,012
1,530 Added 13.86%
12,571 $346,000
Q1 2020

May 04, 2020

SELL
$13.63 - $33.98 $40,194 - $100,207
-2,949 Reduced 21.08%
11,041 $177,000
Q4 2019

Feb 06, 2020

BUY
$16.12 - $24.98 $44,330 - $68,695
2,750 Added 24.47%
13,990 $334,000
Q4 2019

Feb 04, 2020

SELL
$16.12 - $24.98 $1,080 - $1,673
-67 Reduced 0.59%
11,240 $231,000
Q3 2019

Nov 12, 2019

BUY
$15.49 - $25.78 $175,145 - $291,494
11,307 New
11,307 $199,000
Q2 2018

Aug 02, 2018

SELL
$20.0 - $29.72 $11.8 Million - $17.5 Million
-589,460 Closed
0 $0
Q1 2018

May 04, 2018

SELL
$21.69 - $32.99 $190,655 - $289,982
-8,790 Reduced 1.47%
589,460 $13.3 Million
Q4 2017

Feb 01, 2018

BUY
$26.43 - $31.78 $598,903 - $720,134
22,660 Added 3.94%
598,250 $18.7 Million
Q3 2017

Oct 27, 2017

BUY
$11.61 - $31.21 $6.28 Million - $16.9 Million
541,270 Added 1577.13%
575,590 $18 Million
Q2 2017

Aug 07, 2017

BUY
N/A
34,320
34,320 $589,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $10.6B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.